api-usage
SignalPGx
GeneCodex
Genomics
NeoGenomics Pharma Services
SignalPGx is a global pharmacogenomics reporting and medication intelligence platform built for laboratories, hospital systems, provider networks, clinics, pharmacy partners, and healthcare enterprises.
The platform helps healthcare organizations turn genotype data into clear, evidence-backed medication guidance through physician-reviewed PGx reports, SignalAI-assisted interpretation, living reanalysis, and EHR-ready integrations.
SignalPGx supports multiple genotype input formats, including VCF, Agena MassARRAY, CSV, and custom laboratory files. It currently supports 50+ pharmacogenes and approximately 950 medications with clinical PGx guidance.
At the center of the platform is the Medication Intelligence Graph, which connects gene-drug relationships, medication guidance, drug labeling, clinical evidence, and patient-specific medication context. SignalPGx also includes a Living Patient Passport, allowing PGx insights to remain useful as medications, evidence, and guidelines change over time.
Key capabilities include white-label PGx reporting, physician review workflows, SignalAI clinical interpretation support, medication simulation, living reanalysis and alerts, reimbursement documentation support, and integrations through SMART on FHIR, HL7/FHIR, CDS Hooks, and REST APIs.
SignalPGx is designed with enterprise-grade security, tenant isolation, role-based access control, audit logging, encryption, and scalable multi-region AWS infrastructure.
SignalPGx supports clinical decision-making and PGx reporting workflows but does not replace physician judgment. Prescribing decisions remain with the treating healthcare provider.
SignalPGx's answer:
SignalPGx combines pharmacogenomics reporting, medication intelligence, physician-reviewed workflows, SignalAI-assisted interpretation, living reanalysis, and EHR-ready integrations in one platform.
Unlike static PGx report generators, SignalPGx is designed to keep medication guidance useful over time as medications, evidence, and clinical guidelines change. It supports white-label PGx reports, VCF, Agena MassARRAY, CSV, and custom file formats, plus integrations through SMART on FHIR, HL7/FHIR, CDS Hooks, and REST APIs.
SignalPGx also includes enterprise-grade security features such as tenant isolation, RBAC, audit logging, encryption, and scalable multi-region AWS infrastructure.
SignalPGx's answer:
SignalPGx is built for organizations that need more than a one-time PGx PDF. It helps labs, hospital systems, provider networks, clinics, and healthcare enterprises turn genotype data into evidence-backed medication guidance with clinical review, EHR integration, and long-term reanalysis.
Key advantages include white-label reporting, physician-reviewed workflows, SignalAI interpretation support, Medication Intelligence Graph, Living Patient Passport, medication simulation, reimbursement documentation support, and modern interoperability through SMART on FHIR, HL7/FHIR, CDS Hooks, and REST APIs.
It is designed for real clinical workflows, not just report generation.
SignalPGx's answer:
SignalPGx's answer:
SignalPGx is built for laboratories, hospital systems, health systems, provider networks, clinics, pharmacy partners, and healthcare enterprises that want to launch or expand pharmacogenomics reporting and medication intelligence workflows.
The platform is especially useful for organizations that need physician-reviewed PGx reports, branded reporting, EHR integration, medication guidance, evidence-backed interpretation, living reanalysis, and secure enterprise deployment.
SignalPGx's answer:
SignalPGx was created because pharmacogenomics deserves more than a static report. Many PGx workflows still depend on PDFs, manual interpretation, disconnected evidence sources, and limited EHR integration.
SignalPGx was built to turn genotype data into living medication intelligence. The platform brings together evidence-backed PGx reporting, physician-reviewed workflows, SignalAI-assisted interpretation, branded reports, EHR integrations, medication simulation, and long-term reanalysis so PGx results can remain useful after the first report is released.
The goal is simple: help healthcare organizations make PGx reporting clearer, faster, more connected, and more clinically useful.
SignalPGx's answer:
SignalPGx uses modern cloud, interoperability, security, and clinical data technologies to support enterprise PGx reporting and medication intelligence.
Primary technologies and standards include AWS cloud infrastructure, multi-region deployment architecture, tenant isolation, role-based access control, audit logging, encryption in transit and at rest, REST APIs, SMART on FHIR, HL7/FHIR, CDS Hooks, LOINC, HGNC, RxNorm, and structured PGx data processing.
The platform also supports VCF, Agena MassARRAY, CSV, and custom laboratory file formats, with SignalAI-assisted interpretation and evidence mapping across trusted PGx and medication sources.